Background-Cough is a common and troublesome symptom in cryptogenic fibrosi
ng alveolitis (CFA) but the mechanisms responsible are not known. The cough
threshold to inhaled capsaicin is increased in asthma and chronic obstruct
ive pulmonary disease (COPD) where lung volumes are increased, but the rela
tionship between cough response and symptom intensity has not been studied
in CFA where lung volumes are reduced.
Methods-Capsaicin challenge tests were performed on 15 subjects with proven
CFA and 96 healthy controls. Symptoms, as assessed by daily diary card cou
gh score and by visual analogue scale (VAS), were related to the capsaicin
sensitivity (C5) and compared with lung volumes. Volume restriction was pro
duced in a group of 12 normal healthy subjects by a plastic shell tightly s
trapped to the chest wall. Capsaicin challenge tests were performed in thes
e subjects, both strapped and unstrapped, to determine whether volume restr
iction altered the cough reflex.
Results-The median C5 response in normal subjects was more than 500 muM com
pared with 15.6 muM in those with CFA (p<0.001). The C5 response of the CFA
patients was not related to symptoms of cough (whether measured by diary c
ard or by VAS), nor was it related to percentage predicted total lung capac
ity (TLC) or forced vital capacity (FVC). Volume restriction of normal subj
ects with chest strapping successfully restricted lung volumes to levels si
milar to that of the CFA patients but did not change the sensitivity to cap
saicin.
Conclusions-The cough reflex measured using capsaicin is markedly increased
in patients with CFA. This increase is not the result of alterations in th
e deposition of inhaled particles of capsaicin brought about by volume rest
riction. It could be related to reduced lung compliance leading to sensitis
ation of rapidly adapting receptors, other mechanical changes, or to destru
ction of pulmonary C fibres secondary to interstitial inflammation. The cap
saicin test may be a useful method of objectively monitoring cough propensi
ty in CFA.